Ibex's Galen AI pathology analysis software gets FDA nod

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has designated Ibex Medical Analytics' Galen artificial intelligence (AI) software for pathology image analysis as a breakthrough device. The designation is granted to technologies with the potential to better diagnose cancer.

The AI-powered software supports pathologists in the detection of various types of cancer. Galen aims to reduce diagnosis time and boost productivity.


Copyright © 2021 LabPulse.com
 

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?